155 related articles for article (PubMed ID: 4179400)
1. Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.
Alexander WD; Harden RM; McLarty D; Shimmins J
Metabolism; 1969 Jan; 18(1):58-62. PubMed ID: 4179400
[No Abstract] [Full Text] [Related]
2. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
Alexander WD; McLarty DG; Robertson J; Shimmins J; Brownlie BE; Harden RM; Patel AR
J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916
[No Abstract] [Full Text] [Related]
3. Treatment of thyrotoxicosis with lithium carbonate.
Lazarus JH; Richards AR; Addison GM; Owen GM
Lancet; 1974 Nov; 2(7890):1160-3. PubMed ID: 4139588
[No Abstract] [Full Text] [Related]
4. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
Valentini F; Reschini E; Lodeserto A; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):396-403. PubMed ID: 4185869
[No Abstract] [Full Text] [Related]
5. Plasma glycerol and glycerol turnover during treatment of hyperthyroidism.
Tibbling G; Cederquist E; Lundquist A
Clin Chim Acta; 1969 Aug; 25(2):189-98. PubMed ID: 4184576
[No Abstract] [Full Text] [Related]
6. Combined carbimazole-131-I treatment for thyrotoxicosis.
McDougall IR; Greg WR
Scott Med J; 1972 Feb; 17(2):57-61. PubMed ID: 4111803
[No Abstract] [Full Text] [Related]
7. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
Etling N
Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
[No Abstract] [Full Text] [Related]
8. Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.
Alexander WD; Harden RM; Shimmins J
Lancet; 1966 Nov; 2(7472):1041-4. PubMed ID: 4162502
[No Abstract] [Full Text] [Related]
9. Effect of pretreatment with carbimazole in patients with thyrotoxicosis subsequently treated with radioactive iodine.
Goolden AW; Fraser TR
Br Med J; 1969 Aug; 3(5668):443-4. PubMed ID: 4185887
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
Hales I; Stiel J; Reeve T; Heap T; Myhill J
J Clin Endocrinol Metab; 1969 Jul; 29(7):998-1001. PubMed ID: 4183236
[No Abstract] [Full Text] [Related]
11. Treatment of thyrotoxicosis based on thyroidal suppressiblity.
Alexander WD; Harden RM; Shimmins J; McLarty D; McGill P
Lancet; 1967 Sep; 2(7518):681-4. PubMed ID: 4167095
[No Abstract] [Full Text] [Related]
12. Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.
Horton PW; Millar WT; McLarty DG; Alexander WD
Clin Endocrinol (Oxf); 1975 Jul; 4(4):357-62. PubMed ID: 168992
[TBL] [Abstract][Full Text] [Related]
13. The variation in serum triiodothyronine (T3) achieved during suppression testing in thyrotoxicosis.
Wilkin TJ; Isles TE; Newton RW; Gunn A; Crooks J; Beck JS
Clin Endocrinol (Oxf); 1978 Dec; 9(6):549-55. PubMed ID: 747896
[No Abstract] [Full Text] [Related]
14. Thyroid suppressibility: follow-up for two years after antithyroid treatment.
Lowry RC; Lowe D; Hadden DR; Montgomery DA; Weaver JA
Br Med J; 1971 Apr; 2(5752):19-22. PubMed ID: 4101408
[TBL] [Abstract][Full Text] [Related]
15. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
Wils JA; Kloppenborg PW
J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
[No Abstract] [Full Text] [Related]
16. Carbimazole treatment in early pregnancy. Ultrastructural and biochemical observations on the thyroid glands of two twin-fetuses.
Olin P; Ekholm R
Acta Paediatr Scand; 1971 Sep; 60(5):565-70. PubMed ID: 4106725
[No Abstract] [Full Text] [Related]
17. Neonatal thyrotoxicosis.
Hopton DS; Wade JS
Proc R Soc Med; 1969 Aug; 62(8):817. PubMed ID: 4185737
[No Abstract] [Full Text] [Related]
18. [Inorganic and organic phases of radioiodine metabolism in the thyroid in Basedow patients treated with synthetic thyroid antagonists].
Valentini F; Lodeserto A; Reschini E; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):385-95. PubMed ID: 4186148
[No Abstract] [Full Text] [Related]
19. Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.
Alexander WD; Harden RM; Shimmins J; McLarty D; McGill P
J Clin Endocrinol Metab; 1967 Dec; 27(12):1682-9. PubMed ID: 4168655
[No Abstract] [Full Text] [Related]
20. Assessment of thyroid function during and after treatment of thyrotoxicosis.
McLarty DG; Alexander WD
J Clin Pathol; 1975 Mar; 28(3):251-4. PubMed ID: 47343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
